Vimarsana
Biggest News Aggregation in the World

Expert Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expert Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expert Consortium Today - Breaking & Trending Today

The Safety of Rwanda Act: a pointless exercise in performative cruelty - Vimarsana News

The Safety of Rwanda Act: a pointless exercise in performative cruelty

Why do politicians have such a low opinion of British people’s compassion to think this policy is a vote winner, asks Martin McKee Late on 22 April 2024 the Safety of Rwanda (Asylum and Immigration) Bill cleared its final stages in the UK parliament.1 Its stated purpose is to enable the government to send migrants who have reached the UK to Rwanda. The bill was deemed necessary because the government’s previous attempts to send migrants to Rwanda were thwarted, firstly by a series of temporary blocks (Rule 39 orders) imposed by the European Court of Human Rights, and then by the UK Supreme...

Source: bmj.com
Qbtech, Global Leader in Objective ADHD Testing, Opening U.S. Headquarters in Houston - Vimarsana News

Qbtech, Global Leader in Objective ADHD Testing, Opening U.S. Headquarters in Houston

Texas office will serve as home base for U.S. operations, expanding the company's presence in the market and contributing to the local economy Qbtech, the global leader in objective ADHD testing

MAMS Adaptive Trial Shows Promise for Future Progressive MS Treatments - Vimarsana News

MAMS Adaptive Trial Shows Promise for Future Progressive MS Treatments

A multi-arm multi-stage adaptive trial for progressive multiple sclerosis can make it possible to test new treatments within a shorter period of time.

Global T-Cell Scientists Unite in Fight Against Infectious Disease - Vimarsana News

Global T-Cell Scientists Unite in Fight Against Infectious Disease

Read Time: The Global T cell Expert Consortium (GTEC) officially kicked-off on December 16 with eleven founding members from eight labs across three continents all focused on maximising the use and direction of T cell research in the global battle against COVID-19 and other infectious diseases. According to the eminent group of world-leading experts in T cell research, epidemiology, vaccine research and global public health, the path to long-term control of COVID-19 will require a combination of antibody and T cell assessments, standardisation in research, and increased data pools – w...